New Delhi [India], January 25 (ANI): Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla on Tuesday congratulated the deserving individuals who will receive the Padma awards this year.
New Delhi [India], January 25 (ANI): Serum Institute of India (SII) Chairman and Managing Director Cyrus Poonawalla will be conferred with Padma Bhushan, announced the Centre on Tuesday, on the eve of the 73rd Republic Day.
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.
Gaithersburg [US], January 10 (ANI): Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), on Monday, announced a regulatory submission to the South African Health Products Re
Gaithersburg/Pune (Maryland/Maharashtra)[US/India], December 29 (ANI): Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), the world's largest vaccin
Pune (Maharashtra) [India], December 28 (ANI): Serum Institute of India on Tuesday expressed gratitude to the Union Health Ministry for granting Emergency Use Authorization for its COVID-19 vaccine Covovax.
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
New Delhi [India], December 14 (ANI): Chief Executive Officer of the Serum Institute of India Adar Poonawalla on Tuesday said that they are working towards developing a vaccine booster shot which is more effective against Omicron virus.
New Delhi [India], December 11 (ANI): The Subject Expert Committee (SEC) under Central Drugs Standard Control Organization (CDSCO) has said COVID-19 that booster doses cannot be recommended without clinical trials.
Ankara [Turkey], December 10 (ANI/Sputnik): Turkish security services arrested four men suspected of setting an explosive device that was supposed to go off in the southeastern city of Siirt, where President Recep Tayyip Erdogan was participating in a rally, NTV broadcaster reported on Frida
Pune (Maharashtra) [India], December 9 (ANI): Serum Institute of India (SII) executive director Suresh Jadhav, who played an instrumental role in the field of vaccine manufacturing in India, passed away on Wednesday.